SEC Stock Data Quick Answer CleanCore Solutions, Inc. reported Stockholders Equity of $1.47 million for fiscal year 2025. CleanCore Solutions, Inc. Stockholders Equity — Annual History Fiscal Year Stockholders Equity YoY Change 2025 $1.47M -60.8% 2024 $3.74M +114.0% 2023 $1.75M +128.1% 2022 -$6.20M -3.2% 2022 -$6.01M — Quarterly Stockholders Equity Quarter Ending Stockholders Equity YoY QoQ December 31, … Read more
Quick Answer CleanCore Solutions, Inc. reported Cash and Equivalents of $1.46 million for fiscal year 2025. CleanCore Solutions, Inc. Cash and Equivalents — Annual History Fiscal Year Cash and Equivalents YoY Change 2025 $1.46M -27.6% 2024 $2.02M +412.9% 2023 $393.2K — Quarterly Cash and Equivalents Quarter Ending Cash and Equivalents YoY QoQ December 31, 2025 … Read more
Quick Answer CleanCore Solutions, Inc. reported Total Assets of $8.47 million for fiscal year 2025. CleanCore Solutions, Inc. Total Assets — Annual History Fiscal Year Total Assets YoY Change 2025 $8.47M +13.2% 2024 $7.48M +22.8% 2023 $6.09M — Quarterly Total Assets Quarter Ending Total Assets YoY QoQ December 31, 2025 $101.11M +1550.1% -45.6% September 30, … Read more
Quick Answer CleanCore Solutions, Inc. reported Net Income of -$6.74 million for fiscal year 2025. CleanCore Solutions, Inc. Net Income — Annual History Fiscal Year Net Income YoY Change 2025 -$6.74M -195.5% 2024 -$2.28M — Quarterly Net Income Quarter Ending Net Income YoY QoQ December 31, 2025 -$104.36M -10283.8% -680.7% September 30, 2025 -$13.37M -1461.5% … Read more
Quick Answer CleanCore Solutions, Inc. reported Total Revenue of $2.07 million for fiscal year 2025. CleanCore Solutions, Inc. Total Revenue — Annual History Fiscal Year Total Revenue YoY Change 2025 $2.07M +29.2% 2024 $1.60M — Quarterly Total Revenue Quarter Ending Total Revenue YoY QoQ December 31, 2025 $1.07M +315.5% +18.1% September 30, 2025 $904.7K +147.9% … Read more
Quick Answer CleanCore Solutions, Inc. reported Total Revenue of $2.07 million for fiscal year 2025. CleanCore Solutions, Inc. — Key Financials by Year Metric 2025 2024 2023 2022 Total Revenue $2.07M+29.2% $1.60M — — Net Income -$6.74M-195.5% -$2.28M — — Total Assets $8.47M+13.2% $7.48M+22.8% $6.09M — Cash and Equivalents $1.46M-27.6% $2.02M+412.9% $393.2K — Stockholders Equity … Read more
Quick Answer Zomedica Corp. reported Shares Outstanding of 979.95 million shares for fiscal year 2025. Zomedica Corp. Shares Outstanding — Annual History Fiscal Year Shares Outstanding YoY Change 2025 979.95M +0.0% 2024 979.95M +0.0% 2023 979.95M +0.0% 2022 979.95M +0.0% 2021 979.90M +52.6% 2020 642.04M +494.3% 2019 108.04M +10.7% 2018 97.60M +8.2% 2017 90.23M +7.5% … Read more
Quick Answer Zomedica Corp. reported Gross Profit of $21.68 million for fiscal year 2025. Zomedica Corp. Gross Profit — Annual History Fiscal Year Gross Profit YoY Change 2025 $21.68M +13.6% 2024 $19.09M +10.2% 2023 $17.32M +28.6% 2022 $13.47M +341.0% 2021 $3.05M — 2020 $0.00 — Quarterly Gross Profit Quarter Ending Gross Profit YoY QoQ September … Read more
Quick Answer Zomedica Corp. reported Operating Income of -$84.35 million for fiscal year 2025. Zomedica Corp. Operating Income — Annual History Fiscal Year Operating Income YoY Change 2025 -$84.35M -65.2% 2024 -$51.05M -18.0% 2023 -$43.27M -97.4% 2022 -$21.92M -2.6% 2021 -$21.37M -27.5% 2020 -$16.76M +15.3% 2019 -$19.78M -19.3% 2018 -$16.58M -105.1% 2017 -$8.08M -41.2% 2016 … Read more
Quick Answer Zomedica Corp. reported R&D Expense of $7.17 million for fiscal year 2025. Zomedica Corp. R&D Expense — Annual History Fiscal Year R&D Expense YoY Change 2025 $7.17M -1.4% 2024 $7.27M +26.5% 2023 $5.74M +122.8% 2022 $2.58M +54.1% 2021 $1.67M -79.2% 2020 $8.04M -22.2% 2019 $10.35M +0.3% 2018 $10.32M +275.0% 2017 $2.75M +81.2% 2016 … Read more